Human transposable element
Human transposable element
批准号:
8138944
负责人:
HAIG H. KAZAZIAN
金额:
$19.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-24 至 2011-06-30
关键词:
AccountingAffectAgeBiologyCultured CellsDNA Transposable ElementsDNA-Directed DNA PolymeraseDNA-Directed RNA PolymeraseDefectDevelopmentDouble Strand Break RepairElementsEmbryonic DevelopmentEventFemaleGenerationsGenomeGerm CellsHumanIndiumKnowledgeL1 ElementsMammalsMeiosisMethylationMusMutagensNeuronsPaste substancePhenotypePoly AProcessRNARNA DegradationRNA SequencesRNA-Directed DNA PolymeraseRelative (related person)RetrotranspositionRetrotransposonRoleSmall Interfering RNASmall RNASomatic CellSpecificityStagingTestingTimeTranscriptTransgenic Micebasecell transformationcell typemalemammalian genomemouse genomemouse modelnovelpromoterrepaired
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): LINE-1, or L1, elements, are the most prolific and prominent mobile elements in mammalian genomes. In the human and mouse genomes, active L1s and their relics account for 17-20% of the genome mass. By providing activities necessary for mobility of Alu and other elements, they indirectly account for another 10- 12% of these genomes. L1 retrotransposons move through a duplicative "copy and paste" mechanism. In this renewal proposal, we attack a number of unanswered questions concerning the timing and cell type specificity of retrotransposition, the mechanism of L1 insertion into the genome, and the role of siRNA produced by the bidirectional L1 promoter in the control of retrotransposition. In Specific Aim 1, we seek to determine the fraction of total retrotransposition events that occur in male germ cells, female germ cells, and in the early stages of embryonic development. We also wish to determine whether retrotransposition decreases with age, is suppressed after a number of generations, and is increased by defects in methylation or DMA double strand break repair. In Specific Aim 2 we develop further evidence of the role of siRNA derived from the L1 bidirectional promoter. We also characterize the small RNA sequences derived from L1 RNA, and determine whether specific knockdown of L1 transcript levels alters the phenotype of transformed cells. In Specific Aim 3, we will test a novel mechanism of L1 integration. Postulated features of this mechanism are 1) 5' truncation is due to 5' degradation of L1 RNA, 2) template jumping of reverse transcriptase is a key feature of the mechanism, and 3) synthesis of DMA second strand is carried out by a DNA polymerase activity of L1 reverse transcriptase. In Specific Aim 3A we determine which RNA polymerase transcribes L1 and how the RNA is processed (capped and polyadenylated). In Specific Aim 3B we determine the processes involved in L1 RNA degradation, in particular, whether deadenylation, decapping and 5' degradation are involved and whether a significant fraction of L1 RNA is rapidly 5' degraded. These studies will increase greatly our knowledge of the biology of L1 retrotransposition. In addition, they will provide important new information towards the effort to use L1 as a random insertional mutagen in mammals.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.gde.2012.02.006
发表时间:
2012-06
期刊:
CURRENT OPINION IN GENETICS & DEVELOPMENT
影响因子:
4
作者:
[Hancks, Dustin C., Kazazian, Haig H., Jr.]
通讯作者:
Kazazian, Haig H., Jr.
An important role for RUNX3 in human L1 transcription and retrotransposition.
RUNX3 在人类 L1 转录和逆转录转座中发挥重要作用。
DOI:
10.1093/nar/gkg663
发表时间:
2003
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Yang,Nuo, Zhang,Lin, Zhang,Yue, KazazianJr,HaigH]
通讯作者:
KazazianJr,HaigH
Retrotransposition in Health and Disease
-
批准号:9105045
-
项目类别:
-
资助金额:$53.25万
-
财政年份:2012
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Retrotransposition in Health and Disease
-
批准号:8638030
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2012
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Retrotransposition in Health and Disease
-
批准号:8826767
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2012
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Retrotransposition in Health and Disease
-
批准号:8461147
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2012
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Retrotransposition in Health and Disease
-
批准号:8296918
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2012
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
The role of retrotransposons in autism spectrum disorders
-
批准号:8046942
-
项目类别:
-
资助金额:$207.86万
-
财政年份:2010
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Augmenting GWAS with Retrotransposon Polymorphisms
-
批准号:7811559
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2009
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Augmenting GWAS with Retrotransposon Polymorphisms
-
批准号:7943987
-
项目类别:
-
资助金额:$50.7万
-
财政年份:2009
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Preclinical gene correction of hemophilia A
-
批准号:7788859
-
项目类别:
-
资助金额:$8.16万
-
财政年份:2007
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Preclinical gene correction of hemophilia A
-
批准号:8136424
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2007
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Preclinical gene correction of hemophilia A
-
批准号:7263382
-
项目类别:
-
资助金额:$40.95万
-
财政年份:2007
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Preclinical gene correction of hemophilia A
-
批准号:7595937
-
项目类别:
-
资助金额:$39.54万
-
财政年份:2007
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Preclinical gene correction of hemophilia A
-
批准号:7393720
-
项目类别:
-
资助金额:$39.54万
-
财政年份:2007
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Human variation in retrotransposon activity
-
批准号:7038290
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2005
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Human variation in retrotransposon activity
-
批准号:7198121
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2005
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
FASEB Conference: Mamalian Mobile Elements
-
批准号:6940558
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Human variation in retrotransposon activity
-
批准号:7390392
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2005
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Human variation in retrotransposon activity
-
批准号:6870726
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2005
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Gene correction for Hemophilia A
-
批准号:6832800
-
项目类别:
-
资助金额:$44.61万
-
财政年份:2003
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
Modeling gene therapy of Hemophilia A via liver directed gene expression
-
批准号:6664067
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2002
-
负责人:HAIG H. KAZAZIAN
-
依托单位:
海外基金